New-Generation cancer pill aims for fewer side effects, targets brain tumors
Disease control
Recruiting now
This study is testing a new oral drug called SPR1020 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers hope this new, more targeted drug may shrink …
Phase: PHASE1, PHASE2 • Sponsor: Shanghai SciBrunch Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC